10th Annual Cardiometabolic Health Congress
The 10th annual Cardiometabolic Health Congress will feature "comprehensive, state-of-the-art data and strategies" that can be used when treating patients with cardiovascular and metabolic disease. Presenters at the Congress will identify "practical clinical tools essential to combat cardiometabolic risk and the multitude of related comorbidities."
Lipid resuscitation therapy was identified in 1998 as an effective treatment for local anesthetic systemic toxicity. Since then, researchers have developed a better understanding of the risk factors involved and the manner in which lipids work, using both dynamic scavenging and direct cardiotonic effects.
Type 1 diabetes mellitus (T1DM) is treated by necessity with insulin analogues in an attempt to mimic normal physiological insulin profiles. Regardless, this approach is rarely completely successful and most T1DM patients experience fluctuating or suboptimal glucose control, significant hypoglycemia and microvascular tissue complications.